NBI 30545
NBI 30545 is a blood-brain barrier permeable CRF1R antagonist with a Ki value of 3.4 nM for the human receptor. NBI 30545 inhibits CRF-stimulated intracellular cAMP accumulation and ACTH release. NBI 30545 can be used in the research of depression, anxiety disorders and stress-related diseases.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 195054-99-0
- Fòrmula: C22H30N4O3
- Peso molecular:398.51
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CHO | IC50 |
76 nM
Compound: 8
|
Inhibition of [125I]o-CRF binding to CHO cells expressing human CRF1 receptor
Inhibition of [125I]o-CRF binding to CHO cells expressing human CRF1 receptor
|
[PMID: 15341493] |
| Pituitary gland cell | IC50 |
37 nM
Compound: 18n
|
Inhibition of CRF-stimulated ACTH release in cultured rat anterior pituitary cells
Inhibition of CRF-stimulated ACTH release in cultured rat anterior pituitary cells
|
[PMID: 15203140] |
| Pituitary gland cell | IC50 |
76 nM
Compound: 18n
|
Inhibition of CRF-stimulated cAMP production in cultured rat anterior pituitary cells
Inhibition of CRF-stimulated cAMP production in cultured rat anterior pituitary cells
|
[PMID: 15203140] |
In Vitro
NBI 30545 inhibits CRF-stimulated cAMP accumulation in cells expressing the human CRF1 receptor with an IC50 of 76 nM[1].
NBI 30545 inhibits CRF-stimulated ACTH release in cultured rat anterior pituitary cells with an IC50 of 37 nM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. .
Parmacokinetics
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Sprague-Dawley[1]
-
Dosage:10 mg/kg (i.v.); 10 mg/kg (p.o.)
-
Administration:i.v.; single dose; p.o.; single dose
-
Result:Achieved a volume of distribution of 4.7 L/kg, clearance of 43 mL/min/kg, and a half-life of 1.1 h after intravenous administration.
Reached a plasma AUC of 1182 ng/mL·h, brain AUC of 1472 ng/g·h, oral bioavailability of 30.5%, and a brain/plasma ratio of 1.2 after oral administration.
Chemical Information
-
No. CAS 195054-99-0
-
Peso molecular 398.51
-
Fòrmula C22H30N4O3
-
SMILES
N1=C(C=C(N2N=C(C(=C12)C=3C=CC(OC)=CC3OC)C)N(CCOC)CCC)C
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)